Hangzhou Tigermed Consulting Co., Ltd. Class H Financial Overview
Hangzhou Tigermed Consulting Co., Ltd. Class H's market cap is currently HK$42.91B. The company's EPS TTM is HK$0.81; its P/E ratio is 50.79; and it has a dividend yield of 0.82%. Hangzhou Tigermed Consulting Co., Ltd. Class H is scheduled to report earnings on October 28, 2025, and the estimated EPS forecast is HK$0.43. See an overview of income statement, balance sheet, and cash flow financials.
